Smivet BV was founded in 2013 in the Netherlands. The mission of this start-up company is to bring new innovative veterinary medicinal products to the market and by doing so contribute to Animal Health. The company focuses for its internal research pipeline on projects that deliver products for niche markets.
Smivet can also be your partner in the research, development and licensing of veterinary medicinal products and diagnostics.
We can help you to prepare the required documentation for full dossiers, detailed and critical summaries , variations and line extensions. We can provide you with an objective opinion (e.g. gap analysis) of documentation that is ready for submission. We can give a professional assessment of data packages that have already been submitted but that are under scrutiny and provide support for the next step.
We can provide support to your due diligence team relying on 20 years of expertise in research and development of veterinary biologicals for multiple species. This experience can bring added value in the data room, by assessing data available before potential products, portfolios or businesses are obtained in acquisition activities.
R&D projects or interim management
We have an abundance of experience with managing projects, project leaders and portfolios for more than 20 years in different organisations, this is available for you to manage critical periods in your organisation. Or to help you re-invent your organisation, or develop a different R&D strategy.
Smivet BV has its internal research project pipeline (started in 2015) that targets currently 3 different areas concerning multiple animal species. For the first research project proof of concept will be reached in Q2-Q3 2017. Research is performed mainly externally by CROs, Institutes & Universities. IP filing is considered as part of the research performed.
Smivet BV can also advise, support or drive your research projects.
Smivet BV has adapted for some of its projects a platform approach that allows spin off products / intermediates to be commercialised either in veterinary medicine or human medicine. Therefore in the future certain materials will become available for potentially interested parties. These can than be purchased through this section of the website.